Linden Thomas Advisory Services »

Catalyst Pharmaceutical Partners shares owned by Linden Thomas Advisory Services

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Linden Thomas Advisory Services from 13F filings

Historical chart of Linden Thomas Advisory Services investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Linden Thomas Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Linden Thomas Advisory Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $267k 17k 15.94
2023-12-31 $186k 11k 16.81

More positions owned by Linden Thomas Advisory Services

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
salesforce (CRM)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Chemed Corp Com Stk (CHE)
Netflix (NFLX)
Lam Research Corporation (LRCX)
Intuit (INTU)
Gartner (IT)
Adobe Systems Incorporated (ADBE)
Lockheed Martin Corporation (LMT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Linden Thomas Advisory Services

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
LSV Asset Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners